Allogeneic transplantation for Ph(+) acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Allogeneic blood or marrow transplantation (alloBMT) is standard of care for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph(+) ALL) in first complete remission (CR1). The routine pretransplant and posttransplant use of tyrosine kinase inhibitors (TKIs) has dramatically...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood Adv
Glavni autori: Webster, Jonathan A., Luznik, Leo, Tsai, Hua-Ling, Imus, Philip H., DeZern, Amy E., Pratz, Keith W., Levis, Mark J., Gojo, Ivana, Showel, Margaret M., Prince, Gabrielle, Bolaños-Meade, Javier, Gondek, Lukasz P., Ghiaur, Gabriel, Dalton, W. Brian, Jain, Tania, Fuchs, Ephraim J., Gladstone, Douglas E., Gocke, Christian B., Ali, Syed Abbas, Huff, Carol Ann, Borrello, Ivan M., Swinnen, Lode, Wagner-Johnston, Nina, Ambinder, Richard F., Jones, Richard J., Smith, B. Douglas
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2020
Teme:
Transplantation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594402/
https://ncbi.nlm.nih.gov/pubmed/33080006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002945
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items